Atlas Trials

Lei Zheng

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Lei Zheng

RecordFirmDate
Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors (NCT07086768)Lei Zheng2026-01-26
A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer (NCT05604560)Lei Zheng2023-11-08
Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma (NCT03727880)Lei Zheng2019-06-04

Track Lei Zheng automatically

Every clearance here is in the API, with alerts when new ones post.